Pharmaceutical - Anti-virals, Vaccines

Filter

Current filters:

Anti-viralsVaccines

Popular Filters

1 to 25 of 38 results

Pfizer gains rights to CMV vaccine with controlling stake in Redvax

Pfizer gains rights to CMV vaccine with controlling stake in Redvax

06-01-2015

US pharma giant Pfizer has acquired a controlling interest in Redvax GmbH, a spin-off from Redbiotec,…

Anti-viralsMergers & AcquisitionsPfizerPharmaceuticalRedbiotechRedvaxVaccines

GSK shingles vaccine candidate meets Ph III primary endpoint

GSK shingles vaccine candidate meets Ph III primary endpoint

18-12-2014

UK pharma major GlaxoSmithKline today released pivotal Phase III study data to assess the efficacy of…

AgenusAnti-viralsGlaxoSmithKlineHZ/suPharmaceuticalResearchVaccines

China's Ebola vaccine enters clinical trials

China's Ebola vaccine enters clinical trials

18-12-2014

An Ebola vaccine developed by a military-tied research institute has been approved to enter the human…

Anti-viralsChinaPharmaceuticalResearchVaccines

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

13-12-2014

French pharma major Sanofi’s vaccines division, Sanofi Pasteur, has received approval from the US Food…

Anti-viralsFluzonePharmaceuticalRegulationSanofiSanofi PasteurUSAVaccines

US lawmakers introduce Bill to speed Ebola treatments development

30-10-2014

Two US Senators have announced their intention to introduce a bill to speed the development of treatments…

Anti-viralsLegalPharmaceuticalResearchTropical diseasesUSAVaccines

EMA advises GlaxoSmithKline on Ebola vaccine development

29-10-2014

The European Medicines Agency has given scientific advice to UK pharma major GlaxoSmithKline on its development…

Anti-viralsGlaxoSmithKlinePharmaceuticalRegulationResearchVaccines

CSL buys Novartis’ influenza vaccines business for $275 million

CSL buys Novartis’ influenza vaccines business for $275 million

27-10-2014

Swiss pharma major Novartis has agreed to divest its influenza vaccines business to Australia’s CSL…

Anti-viralsbioCSLCSL LimitedFinancialMergers & AcquisitionsNovartisPharmaceuticalVaccines

Vaxart accelerates development of Ebola tablet vaccine

24-10-2014

Privately-held US vaccine developer Vaxart says it is accelerating its Ebola tablet vaccine program.…

Anti-viralsPharmaceuticalResearchVaccinesVaxart

EMA moves further to push Ebola treatments development

EMA moves further to push Ebola treatments development

23-10-2014

During the past months, the European Medicines Agency has put in place a system to give the best possible…

Anti-viralsEuropePharmaceuticalRegulationResearchVaccines

IMS Health identifies 10 events that may transform the delivery of health care

IMS Health identifies 10 events that may transform the delivery of health care

23-09-2014

As the global market for drugs surpasses $1 trillion this year, growing payer scrutiny of value for money…

Anti-viralsFinancialGlobalHealthcarePharmaceuticalRegulationResearchVaccines

US Pharma now developing 44 drugs/vaccines for HIV/AIDS

11-09-2014

The USA’s biopharmaceutical research companies are currently developing 44 medicines and vaccines for…

Anti-viralsPharmaceuticalResearchUSAVaccines

Daiichi Sankyo links with Kaketsuken for Bimmugen sales

28-08-2014

Japanese drug major Daiichi Sankyo has signed a cooperative sales agreement with The Chemo-Sero-Therapeutic…

Anti-viralsBimmugenDaiichi SankyoJapanKaketsukenLicensingMarkets & MarketingPharmaceuticalVaccines

PaxVax signs R&D deal with UC San Diego to develop herpes vaccine

PaxVax signs R&D deal with UC San Diego to develop herpes vaccine

11-06-2014

Privately-held California, USA-based specialty vaccine firm PaxVax has entered into a research and development…

Anti-viralsLicensingPaxVaxPharmaceuticalResearchVaccines

Pharma Summit: Merck’s European president Bruno Strigini highlights importance of innovation

Pharma Summit: Merck’s European president Bruno Strigini highlights importance of innovation

17-03-2014

The president of pharma giant Merck & Co’s (NYSE: MRK) operations in Europe and Canada Bruno Strigini…

Anti-viralsCanadaDiabetesEuropeInterviewsMerck & CoMK-3475OncologyPharmaceuticalRegulationUKVaccines

Modest growth expected for hepatitis B vaccine market

Modest growth expected for hepatitis B vaccine market

12-02-2014

The global hepatitis B virus (HBV) vaccine market value will experience modest growth over the coming…

Anti-viralsDynavax TechnologiesHeplisavHexyonMarkets & MarketingPharmaceuticalSanofiSanofi Pasteur MSDVaccines

BiondVax’ universal flu vaccine matches all six potentially pandemic flu strains in the world

21-01-2014

BiondVax Pharmaceuticals, an Israeli company developing a universal flu vaccine, says it has completed…

Anti-viralsBiondVaxPharmaceuticalResearchVaccines

Leading Chinese hepatitis B vaccine makers stop production; Pfizer drug import halted

03-01-2014

China’s Food and Drug Administration announced on January 2 that the country’s three leading manufacturers…

Anti-viralsAntibiotics and Infectious diseasesAsia-PacificBioKangtaiChinaFluconazolePfizerPharmaceuticalRegulationVaccines

China bans BioKangtai hepatitis B vaccine

26-12-2013

Chinese authorities on Friday issued a circular to ban the use of the recombinant hepatitis B vaccine…

Anti-viralsAsia-PacificBioKangtaiChinaHealthcarePharmaceuticalRegulationVaccines

AstraZeneca’s Fluenz Tetra cleared in EU

AstraZeneca’s Fluenz Tetra cleared in EU

06-12-2013

The European Commission has granted Marketing Authorization to Fluenz Tetra, the product’s maker Anglo-Swedish…

Anti-viralsAstraZenecaEuropeFluenz TetraPharmaceuticalRegulationVaccines

US FDA approves shipment of quadrivalent flu vaccine to health care providers

06-08-2013

The US subsidiary of UK pharma giant GlaxoSmithKline (LSE: GSK) says it has received Food and Drug Administration…

Anti-viralsFluarixGlaxoSmithKlineNorth AmericaPharmaceuticalRegulationVaccines

Bionor Pharma leaps on positive trial results of HIV vaccine Vacc-4x with Revlimid

14-06-2013

Norway-based Bionor Pharma (OSE: BIONOR) saw its shares leap 16% to 3.67 kroner on June 13, after the…

Anti-viralsBionor PharmaCelgenePharmaceuticalResearchRevlimidVacc-4xVaccines

Negative FDA news for AVEO's tivozanib and Dynavax' hep B vaccine

11-06-2013

US biotech firm AVEO Oncology (Nasdaq: AVEO) says that it has received a complete response letter from…

Anti-viralsAstellas PharmaAVEO OncologyBiotechnologyDynavax TechnologiesHeplisavNorth AmericaOncologyPharmaceuticalRegulationtivozanibVaccines

HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst

20-05-2013

While the risks involved in HIV vaccine development have turned Big Pharma away from pursuing a preventative…

Anti-viralsBiotechnologyFinancialHVTN 505PharmaceuticalResearchVaccines

GlaxoSmithKline and Abbott to start production in Ukraine

19-03-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) and the USA's Abbott (NYSE: ABT) are considering launching…

Anti-viralsAntibiotics and Infectious diseasesEuropeGlaxoSmithKlineIndarPharmaceuticalProductionVaccines

1 to 25 of 38 results

Back to top